ABI Optimistic But Vague on Growth Prospects for its Microarray Business | GenomeWeb

Despite rolling out several new gene expression arrays and a new microarray instrument over the past year, Applied Biosystems in its fiscal year-end conference call provided few clues of its expectations for these products over the next year.

The firm last week reported relatively flat earnings for the 2004 fiscal year and said it is looking toward strong growth in its mass spectrometry and applied genomics products units, but company officials yielded little information on its efforts to capture market share specifically in the microarray sector.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.